Latest Articles
- ArticleHematologic modifications in natalizumab-treated multiple sclerosis patientsAn 18-month longitudinal studyClaire Bridel, Yan Beauverd, Kaveh Samii, et al.June 18, 2015
- ArticleAquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMOJoanna Kitley, Mark Woodhall, M. Isabel Leite, et al.June 18, 2015
- ArticleOral contraceptives combined with interferon β in multiple sclerosisCarlo Pozzilli, Laura De Giglio, Valeria T. Barletta, et al.June 18, 2015
- ArticleMyopathy with anti-HMGCR antibodiesPerimysium and myofiber pathologyAli Alshehri, Rati Choksi, Robert Bucelli, et al.June 04, 2015
- Clinical/Scientific NotesWidespread arterial infection by varicella-zoster virus explains refractory giant cell arteritisDon Gilden, Teresa White, Steven L. Galetta, et al.June 04, 2015
- ArticleRandomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosisCris S. Constantinescu, Aliya Asher, Waldemar Fryze, et al.May 21, 2015
- Clinical/Scientific NotesPosterior cortical and white matter changes on MRI in anti–AMPA receptor antibody encephalitisMarwa Elamin, Roisin Lonergan, Ronan P. Killeen, et al.May 21, 2015
Pages
Advertisement